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Introduction

Experimental Methods

In 2021, approximately 600,000 people will perish
to cancer, and of those, 50,000 will be solely
pancreatic cancer. Pancreatic ductal
adenocarcinoma (PDAC) makes up 90% of all
pancreatic cancer cases and is often diagnosed
late stage due to its asymptomatic nature, causing
the patient to have fewer options, most commonly
leading to death, making it one of the deadliest
forms of cancer. Currently, there are no diagnostic
or imaging tools for early detection and this project
intents to address this knowledge gap.

Genetically engineered mice (GEM), models (P48Cre:
LSLKrasG12D; LSL-p53R172H (KPC)) with pre-invasive
pancreatic intraepithelial neoplasia (PanIN) precursor lesions
and control mice (P48:Cre or WT C57BL/6) without pancreatic
lesions metabolic process were analyzed using hyperpolarized
1- 13C pyruvate magnetic resonance spectroscopy (MRS). The
dissolution dynamic nuclear polarization (DNP) operating at 3T
was utilized to hyperpolarize 1-13C pyruvate. The 13C MRS of
hyperpolarized 1- 13C pyruvate were acquired at a 7T Bruker
MRI scanner.
The biochemical development of alanine transaminase (ALT)
and lactate dehydrogenase (LDH) enzyme activity were
assessed. Afterward, deep learning (DL) techniques were
implemented to develop a model and reveal hybrid biomarkers
from the MRI and metabolic imaging to predict early detection of
pancreatic cancer. The model was developed through Bayesian
DL techniques and multi-modal data integration to allow
uncertainty measurements and learn features from imaging
modalities to consider improving prediction accuracy. After
training the model, the learned features from multiple modalities
to identify any correlation between MRI and metabolic imaging
are explored that may lead to the discovery of new hybrid
biomarkers with predictive values for the early detection.

Figure 1
LDH = Lactate Dehydrogenase
ALT = Alanine Aminotransferase

An early-stage biomarker of biomarker of
pancreatic cancer is the conversion of
hyperpolarized (HP) pyruvate to lactate and
alanine.
We are capable of monitoring this metabolic
conversion rate employing hyperpolarized
metabolic imaging. Employing hyperpolarized
magnetic resonance (HP-MR) in unison with
Artificial Intelligence (AI) to detect earlier
premalignant stages of PDAC and even predict
the efficacy of therapy in order to maximize
treatment efficacy. HP-MR allows us to view the
live metabolomics in the area of interest, in this
case the pancreas.
Figure 2
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The real-time 13C MR spectra were acquired in vivo
following injection of hyperpolarized pyruvate. The lactate
production was significantly higher in advanced time
points. The mice were imaged at three different timepoints.

Results
Hyperpolarized alanine-to-lactate signal ratio was
found to decrease through progression from low to
high-grade PanINs. These results demonstrate that
there are significant alterations of ALT and LDH
activities through the transformation from early to
advanced PanINs lesions. Furthermore, we
demonstrated that real-time conversion can be used
as metabolic imaging biomarkers of pancreatic
premalignant lesions, and the appropriate DL
combining feature from the MRI and metabolic
imaging as complementary modalities can lead to
proper prediction of early detection in this KPC GEM
model.
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Figure 4

A visual representation of the experimental method and outcome.

Findings from this emerging combination of DL and hyperpolarization-MRS techniques could potentially be translated into clinics for
detection of pancreatic premalignant lesion in high-risk populations through early screenings with Figure 4 demonstrating the entire
process more visually. Current efforts are ongoing to translate this technology at High-Risk Pancreatic Cancer (HR-PC) clinic at MD
Anderson Cancer Center.
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The live metabolic imaging
is best displayed through
MR spectroscopy (MRS) in
which you can see realtime metabolic conversion.
Through Deep learning (DL)
applied to the AI, we can
swiftly screen this data in
order to catch a preindicator or see efficacy of
treatment after detection.

Figure 3
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